protective immunity – Communicable Diseases Research

A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs

Immunology Original Research

Published on 2024-05-212024-09-05
Journal: Frontiers in immunology [Category] update2024,

[키워드] ferritin hemagglutinin extracellular domain nanoparticle vaccine protective immunity swine influenza virus
[DOI] 10.3389/fimmu.2024.1361323 PMC 바로가기 [Article Type] Immunology Original Research

Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria

article

Published on 2023-01-312024-09-01
Journal: Frontiers in Cellular and Infection Microbiology [Category] 말라리아,

[키워드] antibody malaria naturally acquired immunity Plasmodium vivax protective immunity Vaccine
[Article Type] article

Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity

Article

Published on 2023-01-232023-07-11
Journal: Vaccine [Category] COVID19(2023년),

[키워드] attenuation cold adaptation immunogenicity live vaccine protective immunity SARS-CoV-2 Temperature-sensitive phenotype.
[DOI] 10.1016/j.vaccine.2022.12.019 PMC 바로가기

A mathematical model of the within-host kinetics of SARS-CoV-2 neutralizing antibodies following COVID-19 vaccination

Article

Published on 2023-01-072022-11-15
Journal: Journal of theoretical biology [Category] COVID19(2023년), SARS, 진단,

Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective

글로벌 관점에서 COVID-19 백신 부스터의 물류 판단

Article

Published on 2022-12-312022-09-11
Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종,

Genetic Variants and Protective Immunity against SARS-CoV-2

Review

Published on 2022-12-132023-07-11
Journal: Genes [Category] COVID19(2023년),

[키워드] Coronaviruses COVID-19 genetic resistance protective immunity
[DOI] 10.3390/genes13122355 PMC 바로가기 [Article Type] Review

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

Article

Published on 2022-12-012022-11-15
Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] accompanied Blood clinical investigation Coverage COVID-19 COVID-19 pandemic COVID-19 vaccine cytokine release Diseases effective effort elicit Gam-COVID-Vac Health heterologous prime-boost IgA antibody IgG immune response Immunity immunization immunogenic immunogenicity Infection intranasal intranasal vaccine. intranasally K18-hACE2 transgenic mice less lung immunopathology mice mononuclear cell Mortality mucosal nasal mucosa neutralizing antibody non-human primate pandemic Peripheral blood Prevent proliferation protective immunity provided revaccination robust SARS-CoV-2 SARS-COV-2 infection SARSCoV-2 serum Sputnik V systemic and local the vaccine Transmission vaccination Vaccination strategy Vaccine vaccine candidate variants of concern virus virus infection virus spread
[DOI] 10.1080/22221751.2022.2119169 PMC 바로가기

A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity

COVID-19 회복기에 대한 1년 종단 연구는 항 SARS-CoV-2 체액성 및 세포성 면역의 지속성을 보여줍니다

Article

Published on 2022-12-012022-09-11
Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] 1-year after infection anti-SARS-CoV-2 humoral antibody antibody durability. caused CD4 CD8 CD8 T cell CD8 T cell responses Cell cellular immunity central memory circulating antibodies circulating antibody Cohort convalescent COVID-19 COVID-19 convalescent COVID-19 patient disease disease severity effective IgG level immune Immune components immune memory immune protection Immunity induce Infection information Kinetics maintain memory memory B memory B cell Memory responses memory T cells omicron Omicron variant peptide peptide pool persistence protective immunity provide RBD IgG Re-infection recorded response reveal SARS-CoV-2 SARS-CoV-2 circulating antibodies SARS-COV-2 infection subject Symptom T cell T cell response T cell responses T cells tested the RBD the SARS-CoV-2 variant
[DOI] 10.1080/22221751.2022.2049984 PMC 바로가기 [Article Type] Article

Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies

Article

Published on 2022-11-082022-11-15
Journal: Scientific Reports [Category] SARS, 치료기술,

[키워드] acute respiratory syndrome administration affecting Analysis anti-RBD IgG antibody anti-SARS-CoV-2 AUC automated binding antibody booster clinical settings Cohort collected Control coronavirus correlation COVID-19 cutoff value demonstrated Effectiveness Genscript gold standard Immunity immunoassay in both groups infected patient Mindray NAb neutralization Neutralization assay neutralization test neutralizing antibody population level protective immunity provide pseudovirus R 2 Rapid receiver operating characteristic Research ROC ROC Curve Sample SARS-CoV-2 SARS-CoV-2 infected patient second dose sensitivity shown significantly specificity subjects sVNT sVNT assay symptoms onset tested threshold vaccinated individual Vaccine virus neutralization test was performed
[DOI] 10.1038/s41598-022-21317-x PMC 바로가기

Innate immune mechanisms of mRNA vaccines

Article

Published on 2022-11-082022-11-16
Journal: Immunity [Category] Fulltext, MERS, 유전자 메커니즘,